Molecular targeted therapy for osteosarcoma using glycogen synthase kinase-3 beta (GSK-3β) inhibitors.
Shingo Shimozaki
No relevant relationships to disclose
Norio Yamamoto
No relevant relationships to disclose
Hideji Nishida
No relevant relationships to disclose
Hiroaki Kimura
No relevant relationships to disclose
Akihiko Takeuchi
No relevant relationships to disclose
Takashi Kato
No relevant relationships to disclose
Yu Aoki
No relevant relationships to disclose
Takashi Higuchi
No relevant relationships to disclose
Toshinari Minamoto
No relevant relationships to disclose
Hiroyuki Tsuchiya
No relevant relationships to disclose